Aug 1, 2016 8:30 am EDT EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammation and Pain in Cataract Surgery Patients
Jun 1, 2016 8:30 am EDT EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation and Pain Post Cataract Surgery
May 13, 2016 5:25 pm EDT Eyegate Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update
May 6, 2016 8:30 am EDT EyeGate Pharma Appoints Dr. Brenda K. Mann as Vice President, Research and Development
Apr 26, 2016 8:30 am EDT EyeGate Pharma to Present Four Posters at ARVO 2016 Annual Meeting Supporting Development of CMHA-S
Mar 29, 2016 4:45 pm EDT EyeGate Reports Full-year 2015 Financial Results and Provides Business Update